Everyone’s assuming SMCI rides xAI’s coattails, but I think the narrative overstates direct exposure. Contracts shift, racks get shared, and hyperscalers like NVDA and AVGO still dominate. SMCI’s upside is real, but not a guaranteed rocket.
I’m new to this, but it seems SMCI is literally building xAI’s racks. If those AI workloads explode, SMCI should benefit directly.
Everyone’s cheering SMCI, but momentum fades. If xAI/GCP demand slows, rack orders could crater. I’m not chasing yet.
3.7% implied move on $VRTX options feels light for a GS stage event. If the catalyst is just a slide, liquidity could fade fast. I’m eyeing quick scalp, tight stops, and not chasing. Feels like a wash unless there’s real guidance or partnership news.
Momentum in biotech usually runs with headlines; if $VRTX gets a pop on GS, it likely sticks until volume fades or guidance disappoints.
Feels like noise to me; I’m staying out.
Feels like another meme pump-and-dump cycle. Free Doge always comes with a price tag, and the narrative usually fades faster than a meme. If it’s truly over, why the selling spike now? Feels more like a reset than a real capitulation.
Without real utility, this feels like a liquidity trap.
I’m trimming exposure to $DOGEUSDT and rotating a bit into cash. Volatility like this makes me uneasy holding tiny positions.
